| Literature DB >> 36009423 |
Henrik Lauer1, Cosima Prahm1, Johannes Tobias Thiel1, Jonas Kolbenschlag1, Adrien Daigeler1, David Hercher2,3, Johannes C Heinzel1.
Abstract
The rat median nerve model is a well-established and frequently used model for peripheral nerve injury and repair. The grasping test is the gold-standard to evaluate functional recovery in this model. However, no comprehensive review exists to summarize the course of functional recovery in regard to the lesion type. According to PRISMA-guidelines, research was performed, including the databases PubMed and Web of Science. Groups were: (1) crush injury, (2) transection with end-to-end or with (3) end-to-side coaptation and (4) isogenic or acellular allogenic grafting. Total and respective number, as well as rat strain, type of nerve defect, length of isogenic or acellular allogenic allografts, time at first signs of motor recovery (FSR) and maximal recovery grasping strength (MRGS), were evaluated. In total, 47 articles met the inclusion criteria. Group I showed earliest signs of motor recovery. Slow recovery was observable in group III and in graft length above 25 mm. Isografts recovered faster compared to other grafts. The onset and course of recovery is heavily dependent from the type of nerve injury. The grasping test should be used complementary in addition to other volitional and non-volitional tests. Repetitive examinations should be planned carefully to optimize assessment of valid and reliable data.Entities:
Keywords: allograft; animal; autograft; functional recovery; grasping test; median nerve; nerve crush; nerve repair; nerve transection; rat
Year: 2022 PMID: 36009423 PMCID: PMC9405835 DOI: 10.3390/biomedicines10081878
Source DB: PubMed Journal: Biomedicines ISSN: 2227-9059
Figure 1Schematic representation of the grasping test modified by Papalia et al., 2003 [13].
Figure 2Flow chart of the systematic literature search according to the PRISMA guidelines [27]. The flow chart depicts the selection process of the retrieved studies in chronological order. We used the search terms: “rat”, “median nerve”, “grasping test” and their respective combinations.
Summary of all studies included in this systematic review. FSR: First Signs of Motor Recovery (FSR) MRGS: Maximal Recovery Grasping Strength.
| Study | Content | Rat Strain |
| Type of | Defect Length | Graft Length | Observation Interval | FSR | MRGS |
|---|---|---|---|---|---|---|---|---|---|
| Accioli-De-Vaconcellos et al., 1999 [ | Comparison of fresh or frozen allografts or autografts or allografts repopulated by autologous Schwann cells |
| 64 | Segmental neurotmesis | 10 mm | 20 mm | Every 3 months for 12 months | 3 months for fresh contralateral autograft | 12 months |
| Beck-Broichsitter et al., 2014 [ | Babysitter procedure |
| 20 | Nerve transection | / | / | Weekly for 15 months | Two weeks | 13 weeks |
| Beck-Broichsitter et al., 2014 [ | Pulse magnetic field therapy |
| 24 | Nerve transection | / | / | Weekly for 15 months | Two weeks | 13 weeks |
| J. A. Bertelli & Mira, 1995 [ | Grasping test |
| 65 | Crush injury | / | / | Daily | 8 days | 32 days |
| J. A. Bertelli et al., 1996 [ | Vascularised ulnaris vs. Conventional ulnaris transfer |
| 84 | Nerve transection | ? | 20 mm | Daily | 19 days | 360 days |
| J. A. Bertelli et al., 1998 [ | Effect of neurolysis |
| 30 | Crush injury | / | / | Daily for 14 days + after 21, 42 and 84 days | 10 days | 21 days |
| J. A. Bertelli et al., 2004 [ | 40 mm graft |
| 33 | Nerve transection | ? | 40 mm | Daily for 60 days + after 90, 180, 240, 360 and 510 days | 44 days | ? |
| J. A. Bertelli et al., 2005 [ | Muscle graft |
| 124 | Nerve transection | 8 mm, 18 mm | 10 mm, 20 mm | Daily | 8 mm: 57-65 days 10 mm: 68-73 days | ? |
| J. A. Bertelli et al., 2005 [ | Graft length |
| 84 | Nerve transection | 8 mm, 13 mm, 20 mm, 25 mm | 10 mm, 15 mm, 20 mm, 25 mm | Daily + after 90, 180, 270 and 360 days following onset of recovery | 10 mm: 12–15 days, | 360 days |
| 15 mm: 14–16 days, | |||||||||
| 20 mm: 32–40 days, | |||||||||
| 25 mm: 38–46 days | |||||||||
| J. A. Bertelli et al., 2006 [ | Predegenerated graft vs. normal graft |
| 68 | Nerve transection | 18 mm | 20 mm | Daily + after 90, 180, 270 and 360 days following onset of recovery | 18–22 days | 360 days |
| Casal et al., 2018 [ | Autologous conduits with different patterns of blood supply |
| 120 | Nerve transection | 10 mm | 10 mm | Every 15 days for 100 days after reconstruction | 30 days | 90 days for conventional nerve flap and arterialized neurovenous flap |
| Casal et al., 2020 [ | Evaluation methods of recovery |
| 34 | Nerve transection | 10 mm | 10 mm? | Weekly for 14 weeks | 60 days | 100 days |
| Colonna et al., 2019 [ | Wrapping with collagen conduit |
| 16 | Nerve transection | / | / | After 30, 90, 150 and 210 days | 30 days | 210 days |
| Daeschler et al., 2018 [ | Low intensity ultrasound for axonal regeneration |
| 60 | Nerve transection | / | / | Weekly until 7 weeks post-surgery | Three weeks | 8 weeks |
| Dietzmeyer et al., 2019 [ | Chitosan nerve guides |
| 16 | Nerve transection | 10 mm | 14 mm | Every two weeks for 16 weeks | Six weeks | ? |
| Ferreira et al., 2019 [ | Effect of treadmill exercise after crush injury |
| 21 | Crush injury | / | / | At day 11 and day 21 post-surgery | 11 days | 21 days |
| Fregnan et al., 2016 [ | Chitosan conduits |
| 12 | Nerve transection | 5 mm | 10 mm | Every three weeks for 12 weeks | Six weeks | ? |
| Fregnan et al., 2020 [ | Silk-based nerve conduit |
| 36 | Nerve transection | 10 mm | 12 mm | Every 3 weeks for 24 weeks | 6 weeks | 12 weeks |
| Fornazari et al., 2011 [ | Effect of neurotrophic factor |
| 40 | Nerve transection | / | / | Weekly for 12 weeks | 42 days | 84 days |
| Galtrey & Fawcett, 2007 [ | Characterization of functional tests | 24 | Nerve transection + Crush injury | / | / | Weekly in week 1–4 postoperatively + 6 and 14 weeks postoperatively | crush injury: 10 days nerve transection: 21 days for | 4 weeks for crush injury, 14 weeks for nerve transection | |
| Gambarotta et al., 2015 [ | Local delivery of Neuregulin 1 receptor |
| 15 | Nerve transection | ? | 10 mm | Every 3 weeks for 12 weeks | 6 weeks | 12 weeks |
| Ghizoni et al., 2013 [ | Nandrolen therapy |
| 60 | Nerve transection | ? | 40 mm | Daily up to first signs of recovery + 90 and 180 days postoperatively | 40 days | ? |
| Gigo-Benato et al., 2004 [ | Low-power laser biostimulation after end-to-side neurorrhaphy |
| 16 | Nerve transection | / | / | Biweekly for 16 weeks | 10 weeks | 16 weeks |
| Hanwright et al., 2021 [ | Porcine extracellular matrix nerve wrap |
| 40 | Nerve transection | / | / | Weekly for 15 weeks | 4 weeks | ? |
| Heinzel et al., 2021 [ | Gait analysis |
| 10 | Nerve transection | 7 mm | 7 mm | Weekly for 12 weeks | 4 weeks | 12 weeks |
| Jung et al., 2009 [ | End-to-side neurorrhaphy |
| 45 | Nerve transection | / | / | Preoperatively, 10 and 20 weeks after operation | 10 weeks | 20 weeks |
| Kechele et al., 2011 [ | Suture under tension |
| 40 | Nerve transection | / | / | Daily until recovery + 30, 60, 90, 120, 150 and 180 days postoperatively | 14 days | 180 days |
| Lutz et al., 1999 [ | Effects of systemically applied IGF-1 |
| 32 | Nerve transection | / | / | Every 3–4 weeks | 2 weeks | 15 weeks |
| Lutz, Wei, et al., 1999 [ | Effects of IGF-1 after nerve transection and repair vs. Nerve crushing injury |
| 32 | Nerve transection | / | / | Every two weeks for 15 weeks | 2 weeks | ? |
| Lutz et al., 2000 [ | Selection of donor sites for end-to-side neurorrhaphy |
| 21 | Nerve transection | / | / | After first signs of recovery, 12 and 16 weeks | 4 weeks | 16 weeks |
| Machado et al., 2013 [ | Stretch-induced nerve injury |
| 36 | Crush and stretch injury | / | / | Daily for 30 days | 12 days | 30 days |
| Marchesini et al., 2018 [ | Amnion muscle combined graft conduits |
| 14 | Nerve transection | 15 mm | 15 mm | After 30, 60 and 90 days | 30 days | ? |
| Papalia, Geuna, et al., 2003 [ | Terminolateral neurorrhaphy of the ulnar nerve |
| 20 | Nerve transection | / | / | Preoperatively, 2, 8, 22 and 28 weeks | 22 weeks | ? |
| Papalia, Tos, et al., 2003 [ | Modified device of the grasping test |
| 6 | Nerve transection | / | / | Biweekly | 10 weeks | 16 weeks |
| Papalia et al., 2007 [ | End-to-side neurorrhaphy (radialis) |
| 14 | Nerve transection | / | / | 4, 10, 18, 24 and 30 weeks | 70 days | 210 days |
| Papalia et al., 2013 [ | Vein conduits filled with lipoaspirate-derived entire adipose tissue |
| 20 | Nerve transection | 10 mm | 10 mm (?) | Monthly | 2 months | ? |
| Papalia et al., 2016 [ | Epineural window while end-to-side neurorraphy |
| 19 | Nerve transection | / | / | Preoperatively, 15, 25 and 36 weeks after surgery | 15 weeks | ? |
| Ronchi et al., 2009 [ | Assessment of crush injury |
| 20 | Crush injury | / | / | Preoperatively, every 5 days postoperatively | 15 days | 30 days |
| Ronchi et al., 2017 [ | Delayed nerve repair |
| 36 | Nerve transection | / | / | Every 3 weeks for 6 months | 6 weeks | ? |
| Santos et al., 2012 [ | Early and delayed use of phototherapies in crushed median nerves |
| 24 | Crush injury | / | / | 10 and 21 days postoperatively | 10 days | 21 days |
| Sinis et al., 2005 [ | Conduits filled with Schwann cells |
| 76 | Nerve transection | 20 mm | 20 mm | Weekly after 12 weeks postoperatively for 33 weeks | 8 weeks | 24 weeks |
| Sinis et al., 2006 [ | Cross chest median nerve transfer |
| 12 | Nerve transection | ? | 40 mm | Monthly for 12 months | 5 months | 12 months |
| Sinis et al., 2006 [ | Experiences and results with different synthetically developed materials, cellular and acellular tubes and venous conduits |
| 76 | Nerve transection | ? | 20 mm | ? | Six weeks | ? |
| Sinis et al., 2009 [ | Administration of Deferoxamine |
| 48 | Nerve transection | / | / | Weekly | 4 weeks | 12 weeks |
| Sinis et al., 2011 [ | Hemostatic procedures during nerve reconstruction |
| 36 | Nerve transection | / | / | Weekly | 4 weeks | 12 weeks |
| Stößel et al., 2017 [ | Reflex-based grasping, skilled forelimb reaching and electrodiagnostic evaluation in comparison |
| 16 | Nerve transection | 7 mm | 7 mm | Every 4 weeks | 5 weeks | 12 weeks |
| Werdin et al., 2009 [ | Electrophysical testing |
| 54 | Nerve transection | 20 mm | 20 mm | Weekly after 4 weeks postoperatively for 20 weeks | Neurorrhaphy: 5 weeks Autograft: 12 weeks | 16 weeks |
Strains and sexes of all rats included in the 47 articles which were found to be eligible for this review. * Note that in one included study two different of rat strains were used [19].
| Strain and Sexes * | Female | Male |
|---|---|---|
|
| 23 | 4 |
|
| 5 | 3 |
|
| 1 | 0 |
|
| 12 | 0 |
Groups and nerve models’ distribution in 47 articles (two of them used different models, so this resulted in 49 models in total). I: Crush injury II: Transected nerve with End-to-End repair and/or adjuvant therapies III: Transected nerve with End-to-Side repair and/or adjuvant therapies IV: Isogenic, acellular allogenic or other grafts.
| Group | |
|---|---|
| I | 7 (14.9%) |
| II | 13 (21.2%) |
| III | 8 (17%) |
| IV | 21 (44.7%) |
Figure 3First signs of motor recovery (FSR) in group I-IV. X: mean. Horizontal line: median. dot: outlier.
Figure 4First signs of motor recovery (FSR) following nerve repair with graft length ≤ 14 mm, 15–24 mm and ≥ 25 mm. x: median. horizontal line: mean.
Figure 5First signs of motor recovery (FSR) following repair of the median nerve with autologous nerve grafts (left) compared to other grafts (right) with length ≤ 24 mm. x: median. horizontal line: mean.
Figure 6Maximal recovery grasping strength (MRGS) in end-to-end repair and end-to-side repair. x: median. horizontal line: mean.